TNM Staging and Performance Status Scales
On this page
Direct answer
TNM staging describes a tumour's local extent (T), regional lymph node spread (N) and distant metastasis (M), while performance status scales such as ECOG grade how well a patient can function. Together they decide whether treatment aims at cure or at palliation. Stage IV disease in a patient with poor performance status is usually directed towards palliative care.
What you must remember
- T: size and local invasion of the primary tumour, scored by organ-specific criteria from T0 to T4.
- N: regional lymph node involvement, with N0 meaning no nodal metastasis.
- M: M0 means no distant metastasis and M1 means distant spread, which usually places the disease at stage IV.
- cTNM and pTNM: clinical staging is assigned before treatment, and pathological staging after resection may change the stage.
- ECOG scale: graded from 0 (fully active) to 5 (dead), with 0 and 1 generally fit for curative intent.
- ECOG 2 to 4: ambulatory but unable to work at 2, limited self-care at 3, and completely disabled at 4.
- Karnofsky scale: scored from 0 to 100 in steps of 10, with 100 denoting normal function and many trials using 60 or above as an eligibility threshold.
How staging and performance status jointly decide treatment
Staging describes the disease and performance status describes the person, and both are needed before the intent of treatment is set. The steps below run from anatomy to the agreed goal of care.
- Stage the tumour anatomically. Assign T, N and M from imaging, endoscopy and histology.
- Group the stage. Combine T, N and M into stages I to IV, with stage IV covering most cases of distant metastasis.
- Score performance status. Use ECOG or Karnofsky, based on activity, self-care and ability to work, and record the score at each visit.
- Match fitness to intent. Good performance status with localised disease supports curative surgery or chemoradiation, while poor status shifts the aim.
- Check organ reserve. Renal, hepatic and cardiac function and comorbidity refine the fitness assessment and the choice of drugs.
- Define the goal. Curative treatment, life-prolonging palliation or supportive care is agreed with the patient and documented.
Where the exam tries to catch you
Questions test whether the stage is read together with the patient's fitness, not on its own.
- Trap: Stage IV disease is always untreatable. Correct: metastatic germ cell tumours of the testis are often curable with systemic chemotherapy, so stage alone never sets the intent.
- Trap: An ECOG 3 patient receives the same intensive chemotherapy as an ECOG 0 patient. Correct: poor performance status predicts toxicity and poor response, so the regimen is reduced or the goal is changed to palliation.
- Trap: The TNM stage is fixed at diagnosis. Correct: pathological staging after surgery can change the stage, which is why clinical and pathological stages are recorded separately.
Frequently asked questions
What do the T, N and M components of TNM staging describe?
T describes the size and local extent of the primary tumour, N describes regional lymph node involvement, and M describes distant metastasis. Each component is scored by organ-specific criteria, and the three are then combined into a stage from I to IV.
What is the difference between clinical and pathological TNM staging?
Clinical TNM staging is assigned before treatment from imaging, endoscopy and biopsy, whereas pathological TNM staging is assigned after surgical resection. The pathological stage can differ from the clinical stage and is generally used to guide adjuvant therapy.
What does an ECOG performance status of 2 mean?
An ECOG performance status of 2 means the patient is ambulatory and capable of self-care but unable to work, and is up and about for more than half of waking hours. Such patients are often considered for treatment at reduced intensity.
What Karnofsky score is usually needed for fitness for systemic chemotherapy?
Many trials and clinical practice use a Karnofsky performance score of 60 or above as an eligibility threshold for systemic chemotherapy. The score runs from 0 to 100 in steps of 10, with 100 denoting normal function.
Why are performance status scales used alongside TNM staging?
TNM staging describes how far the cancer has spread, while performance status describes how well the patient can tolerate treatment. Together they decide whether treatment is curative, life-prolonging or purely palliative.